A number of conditions can imitate the appearance of seborrheic dermatitis ( Table 2). A variety of treatments are effective for the treatment of seborrheic dermatitis. The mainstays of treatment ...

Over 2 million Canadians are impacted by seborrheic dermatitis ... played a critical role in bringing this potential best-in-class topical treatment to the United States and Canada markets.” ...

Dear Doctors: I have dandruff, and my doctor says it’s from seborrheic dermatitis. Can you explain what that is? I’ve been using the special shampoo I was given, and it helps. When I stop ...

and seborrheic dermatitis. The condition's precise etiology remains unknown, though it is often triggered by topical corticosteroids. Oral and topical antibiotics are the mainstays of treatment.

ZORYVE is the first topical medication with a new mechanism of action for the condition to be approved in Canada.

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

To find out more, we reached out to several board-certified dermatologists to explain what eczema really is and give us their top picks for the best eczema treatments you can try at home.

This approval marks a significant milestone as the first new topical treatment mechanism for the condition in Canada in over 20 years. Seborrheic dermatitis affects over 2 million Canadians ...

“We would like to thank the Canadian investigators and patients who participated in our ZORYVE clinical trials and who played a critical role in bringing this potential best-in-class topical treatment ...

Sometimes a dry, itchy scalp is better treated with a prescription like Zoryve, a medication for seborrheic dermatitis ... when shopping for the best itchy scalp treatments.

WESTLAKE VILLAGE, Calif. - Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a biopharmaceutical company specializing in immuno-dermatology, announced the regulatory approval by Health Canada for ZORYVE ...

(RTTNews) - Arcutis Canada announced that Health Canada has approved ZORYVE for the treatment of seborrheic dermatitis in patients 9 years of age and older. The Health Canada approval is based on ...